KC
MRK icon

Kinloch Capital’s Merck MRK Stock Holding History

Kinloch Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$578K Buy
4,497
+134
+3% +$15.7K 0.21% 55
2026
Q1 		$525K Sell
4,363
-49
-1% -$5.66K 0.21% 58
2025
Q4 		$464K Buy
4,412
+48
+1% +$4.51K 0.2% 55
2025
Q3 		$366K Buy
4,364
+23
+0.5% +$1.89K 0.16% 60
2025
Q2 		$344K Sell
4,341
-67
-2% -$5.33K 0.16% 61
2025
Q1 		$396K Buy
4,408
+50
+1% +$4.67K 0.19% 61
2024
Q4 		$434K Buy
4,358
+16
+0.4% +$1.65K 0.22% 59
2024
Q3 		$493K Sell
4,342
-1
-0% -$119 0.24% 59
2024
Q2 		$538K Buy
4,343
+264
+6% +$34K 0.28% 55
2024
Q1 		$538K Buy
4,079
+1,846
+83% +$228K 0.28% 53
2023
Q4 		$243K Sell
2,233
-1,959
-47% -$203K 0.15% 65
2023
Q3 		$432K Buy
4,192
+2,218
+112% +$239K 0.27% 52
2023
Q2 		$228K Sell
1,974
-2,189
-53% -$249K 0.14% 63
2023
Q1 		$443K Buy
4,163
+14
+0.3% +$1.51K 0.26% 48
2022
Q4 		$460K Buy
4,149
+17
+0.4% +$1.74K 0.27% 46
2022
Q3 		$356K Buy
4,132
+15
+0.4% +$1.34K 0.23% 52
2022
Q2 		$375K Buy
4,117
+219
+6% +$19.4K 0.24% 52
2022
Q1 		$320K Buy
3,898
+440
+13% +$34.7K 0.19% 58
2021
Q4 		$265K Buy
3,458
+17
+0.5% +$1.35K 0.16% 57
2021
Q3 		$258K Hold
3,441
– – 0.18% 57
2021
Q2 		$268K Sell
3,441
-165
-5% -$12.3K 0.19% 59
2021
Q1 		$265K Hold
3,606
– – 0.2% 56
2020
Q4 		$281K Buy
+3,606
New +$276K 0.24% 56

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kinloch Capital's MRK Position: Q2 2026 in Review

Kinloch Capital increased its Merck (MRK) stake by 3.1% in Q2 2026, buying an estimated $15.7K and bringing the position to 4,497 shares worth $578K. The position accounts for 0.21% of the portfolio, ranked #55.

Kinloch Capital first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kinloch Capital held 4,497 shares of Merck worth $578K as of Q2 2026.
  • Kinloch Capital bought 134 Merck shares in Q2 2026, an estimated $15.7K.
  • Merck made up 0.21% of Kinloch Capital's portfolio in Q2 2026, its #55 holding.
  • Kinloch Capital first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kinloch Capital's 13F filing for Q2 2026, filed 14 Aug 2026.